Back to Agenda
Session 1: Future of Pharmacovigilance – Impact of Globalisation
Session Chair(s)
Doris Irene Stenver, MD, MPA
Independent Pharmacovigilance Adviser, Unique Advice, Denmark
Speaker(s)
Peter Richard Arlett, MD, FFPM, FRCP
Head Data Analytics and Methods Task Force, European Medicines Agency, Netherlands
Data and Evidence to Support Benefit Risk Decisions
Sabine Straus, MD, PHD, MSC
Former PRAC Chair, Medicines Evaluation Board (MEB), Netherlands
Future of PRAC
Shanthi Pal, DRSC, MPHARM
Group Lead, Medicines Safety, Safety & Vigilance, WHO, Switzerland
Pharmacovigilance Systems Strengthening – WHO Perspective
Have an account?
